PTC Therapeutics' IPO

PTC Therapeutics raised a round of funding on June 20, 2013. Investors include Public.

PTC Therapeutics (PTC) is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, small-molecule drugs that target post-transcriptional control …

Articles about PTC Therapeutics' IPO: